Gudrun Boysen - Concepedia

Author

Gudrun Boysen

Rigshospitalet

Also Known As

G Boysen, G. A. Boysen, G. BOYSEN, G. Boysen, GUDRUN BOYSEN, Gudrun Boysen, K. Overgaard, Philipa Wolf, S Jackson

294

Publications

19.3K

Citations

H-Index

155

Concepts

All Affiliations

Rigshospitalet Bispebjerg Hospital University of Copenhagen Copenhagen University Hospital Hvidovre Hospital

About

Gudrun Boysen is an author at Rigshospitalet specializing in medicine, neurology, and stroke.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	64	12.3K
2	Public Health	26	33	7K
3	Health Sciences	8	8	360
4	Law	1	1	13
5	Natural Sciences	1	1	12

Gudrun Boysen

124

Publications

17.1K

Citations

H-Index

Page 1

	Year	Citations
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION Palle Petersen, J Godtfredsen, Gudrun Boysen, The Lancet ThrombosisVenous ThrombosisCardiovascular DiseaseMedicineAtherosclerosis	1989	1.8K
Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Ian Graham, Dan Atar, Knut Borch‐Johnsen, European Journal of Cardiovascular Prevention & Rehabilitation HypertensionAdult Cardiac SurgeryPreventive CardiologyCoronary Artery DiseaseInvited Experts	2007	1.7K
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial Else Charlotte Sandset, Philip M. Bath, Gudrun Boysen, The Lancet ThrombosisHypertensionCardiovascular DiseaseIschemic StrokeMedicine	2011	531
Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study Gudrun Boysen, J Nyboe BMJ	1994	368
Validity of Stroke Diagnoses in a National Register of Patients Lars-Henrik Krarup, Gudrun Boysen, Huma Janjua, Neuroepidemiology	2007	360
Linee guida europee sulla prevenzione delle malattie cardiovascolari nella pratica clinica (versione 2012). Quinta Task Force congiunta della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da rappresentanti di nove società e da esperti invitati) Joep Perk, Daniel De Backer, H. Gohlke, Giornale italiano di cardiologia	2013	345
Reliability of Scandinavian Neurological Stroke Scale Ewa Lindenstrøm, Gudrun Boysen, Lis Waage Christiansen, Cerebrovascular Diseases Cerebrovascular DiseaseNeurological RehabilitationStroke PatientsStroke RehabilitationStroke	1991	338
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) Joep Perk, Guy De Backer, H. Gohlke, International Journal of Behavioral Medicine Preventive MedicineCardiovascular EpidemiologyHealth PolicyCardiovascular DiseaseEuropean Guidelines	2012	315
Fixed Minidose Warfarin and Aspirin Alone and in Combination vs Adjusted-Dose Warfarin for Stroke Prevention in Atrial Fibrillation Annette Lemche Gulløv, Birgitte Gade Koefoed, Palle Petersen, Archives of Internal Medicine	1998	302

Page 1